Sunday, November 21, 2010
Print Current Session:
|
|
Sunday
SESSION XLV:
NEW DEVELOPMENTS IN CAS AND RELATED TECHNIQUES (5-MINUTE TALKS)
Moderators:Daniel G. Clair, MD / Giorgio M. Biasi, MD
|
|
SESSION XLV SCHEDULE | |
11:09 AM - 11:14 AM | Why All The Landmark Trials Supporting CEA To Prevent Strokes From Carotid Stenosis Are Obsolete: When Is Carotid Intervention Indicated? |
Presenters(s):Anne L. Abbott, MD, PhD, FRACP | |
11:15 AM - 11:20 AM | Debate 30: CEA Not CAS Is The Best Treatment For Most Patients With High-Grade Carotid Stenosis |
Presenters(s):Roberto Chiesa, MD | |
11:21 AM - 11:26 AM | Debate 30: CAS Not CEA Is The Best Treatment For Most Patients With High Grade Carotid Stenosis |
Presenters(s):Piergiorgio Cao, MD, FRCS | |
11:27 AM - 11:32 AM | Debate 30: Best Medical Treatment (BMRX) Should Be The Treatment Of Choice For Most Patients With Asymptomatic Carotid Stenosis: They Do Not Require Prophylactic CEA Or CAS |
Presenters(s):A. Ross Naylor, MD, FRCS | |
11:33 AM - 11:38 AM | CAS vs. CEA: What Are The Relative Results For Symptomatic And Asymptomatic Patients From The SVS Registry? |
Presenters(s):Anton N. Sidawy, MD, MPH | |
11:39 AM - 11:44 AM | Debate 31: No Patient Should Undergo CAS Without Embolic Brain Protection |
Presenters(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
11:45 AM - 11:50 AM | Debate 31: Some Patients Should Undergo CAS Without Embolic Brain Protection |
Presenters(s):Franco Perona, MD | |
11:51 AM - 11:56 AM | CAS Is The Treatment Of Choice For Post CEA Symptomatic Restenosis: When Is Observation And Medical Treatment Indicated? |
Presenters(s):Ali F. AbuRahma, MD | |
11:57 AM - 12:08 PM | Panel Discussion / Refreshments Available In 3rd Floor Foyer |
Moderator(s): Michael B. Silva, Jr., MD / Anton N. Sidawy, MD, MPH | |
12:09 PM - 12:14 PM | Current Status Of Gra- Scale Median (GSM) For Detecting Asymptomatic Carotid Plaques At Risk For Causing Stroke: Why Is There Controversy About The Value Of GSM In Assessing Plaque Vulnerability And Risk? |
Presenters(s):Giorgio M. Biasi, MD | |
12:15 PM - 12:20 PM | Is There A Role For CAS In The Presence Of A Carotid String Sign? |
Presenters(s):Carlos H. Timaran, MD | |
12:21 PM - 12:26 PM | 10 Top Tips For CAS Without Complications |
Presenters(s):Ali Amin, MD, RVT, FACS, FACC | |
12:27 PM - 12:32 PM | Subanalysis Of Flow Reversal System (FRS) For Embolic Protection: What Lessons Can Be Learned? |
Presenters(s):Daniel G. Clair, MD | |
12:33 PM - 12:38 PM | Comparison Of Filters And Flow Reversal For Brain Protection As Monitored By TCD And DWI MRI |
Presenters(s):Claudio J. Schönholz, MD | |
12:39 PM - 12:44 PM | Why Were The Results Of CREST And ICSS So Different: Therapeutic Implications |
Presenters(s):Frans L. Moll, MD, PhD | |
12:45 PM - 12:50 PM | Analysis Of Filter Debris From CAS Procedures: Does It Correlate With Duplex GSM Findings And How Does It Help Choose The Best Means Of Embolic Protection? |
Presenters(s):Peter L. Faries, MD, FACS | |
12:51 PM - 12:56 PM | Carotid Stent Fractures: Incidence And Implications |
Presenters(s):Richard J. Powell, MD | |
12:57 PM - 1:02 PM | Open Surgical Technique Getting Exposure Of The ICA To The Base Of The Skull For Aneurysms, etc.: It's Better Than Dislocating The Jaw |
Presenters(s):Michel A. Bartoli, MD / Alain Branchereau, MD | |
1:03 PM - 1:10 PM | Panel Discussion |
Web-Based Presentation | 45.1 - How Can The CREST And ICSS Results Be Reconciled? |
Presenters(s):Christopher K. Zarins, MD | |
Web-Based Presentation | 45.2 - SVS CAS Registry Shows No Difference In Results Between Open And Closed Cell Stents |
Presenters(s):Gregorio A. Sicard, MD | |
END OF SESSION XLV | |
previous | next |